Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
出版年份 2021 全文链接
标题
Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas
作者
关键词
-
出版物
Journal of Personalized Medicine
Volume 11, Issue 11, Pages 1095
出版商
MDPI AG
发表日期
2021-10-27
DOI
10.3390/jpm11111095
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- FAST: A randomised phase II study of zolbetuximab (IMAB362) plus EOX vs EOX alone for first-line treatment of advanced CLDN18.2 positive gastric and gastro-oesophageal adenocarcinoma
- (2021) U. Sahin et al. ANNALS OF ONCOLOGY
- Claudin 18.2 – a FAST-moving target in gastric cancer?
- (2021) A. Athauda et al. ANNALS OF ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Claudin 18.2 expression in various tumor types and its role as a potential target in advanced gastric cancer
- (2020) Jung Yong Hong et al. Translational Cancer Research
- MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
- (2020) Maria Grazia Rodriquenz et al. Journal of Clinical Medicine
- Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
- (2020) A. Arnold et al. Clinical & Translational Oncology
- Targeted Therapies in Advanced Gastric Cancer
- (2020) Timil H. Patel et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- The Significance of the CLDN18-ARHGAP Fusion Gene in Gastric Cancer: A Systematic Review and Meta-Analysis
- (2020) Wei-Han Zhang et al. Frontiers in Oncology
- Dawn of precision medicine on gastric cancer
- (2019) Takahiro Ishii et al. International Journal of Clinical Oncology
- A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study
- (2019) O Türeci et al. ANNALS OF ONCOLOGY
- Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases
- (2019) Irene Coati et al. BRITISH JOURNAL OF CANCER
- Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
- (2019) Matthias Dottermusch et al. VIRCHOWS ARCHIV
- PD-L1 expression in gastroesophageal dysplastic lesions
- (2019) Matteo Fassan et al. VIRCHOWS ARCHIV
- Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives
- (2019) Antonio Pellino et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma
- (2019) Ankur K. Nagaraja et al. Cancer Discovery
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset
- (2018) Atsushi Tanaka et al. Oncotarget
- Loss of Tight Junction Protein Claudin 18 Promotes Progressive Neoplasia Development in Mouse Stomach
- (2018) Susan J. Hagen et al. GASTROENTEROLOGY
- Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
- (2017) Prabhsimranjot Singh et al. Journal of Hematology & Oncology
- Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics
- (2017) Eva-Maria Birkman et al. VIRCHOWS ARCHIV
- HER2Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology
- (2016) Angela N. Bartley et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- A protein and mRNA expression-based classification of gastric cancer
- (2016) Namrata Setia et al. MODERN PATHOLOGY
- HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
- (2016) Federica Grillo et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Update on Epstein-Barr virus and gastric cancer (Review)
- (2015) AYA SHINOZAKI-USHIKU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Down-Regulation of Claudin-18 Is Associated with the Proliferative and Invasive Potential of Gastric Cancer at the Invasive Front
- (2013) Tadayuki Oshima et al. PLoS One
- Expression of claudin-7 and loss of claudin-18 correlate with poor prognosis in gastric cancer
- (2013) Kyong-Hwa Jun et al. International Journal of Surgery
- Epstein-Barr Virus-associated Gastric Carcinoma
- (2012) Jian-Ning Chen et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Claudin-18 gene structure, regulation, and expression is evolutionary conserved in mammals
- (2011) Özlem Türeci et al. GENE
- Loss of tight junction barrier function and its role in cancer metastasis
- (2008) Tracey A. Martin et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
- (2008) U. Sahin et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started